为什么重组对检测开发和生产至关重要

Q4 Biochemistry, Genetics and Molecular Biology

Genetic Engineering & Biotechnology News Pub Date : 2023-10-01 DOI:10.1089/gen.43.10.12

David A. George

{"title":"为什么重组对检测开发和生产至关重要","authors":"David A. George","doi":"10.1089/gen.43.10.12","DOIUrl":null,"url":null,"abstract":"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 Translational MedicineWhy Recombinants Are Essential for Assay Development and ProductionScripps Laboratories says that if native proteins are unavailable, research organizations and diagnostic companies should look to recombinant replacementsDavid A. GeorgeDavid A. GeorgeDavid A. George is director of product research at Scripps Laboratories. Website: scrippslabs.com.Search for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.12AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:David A. George.Why Recombinants Are Essential for Assay Development and Production.Genetic Engineering & Biotechnology News.Oct 2023.28-31.http://doi.org/10.1089/gen.43.10.12Published in Volume: 43 Issue 10: October 13, 2023PDF download","PeriodicalId":50425,"journal":{"name":"Genetic Engineering & Biotechnology News","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Why Recombinants Are Essential for Assay Development and Production\",\"authors\":\"David A. George\",\"doi\":\"10.1089/gen.43.10.12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 Translational MedicineWhy Recombinants Are Essential for Assay Development and ProductionScripps Laboratories says that if native proteins are unavailable, research organizations and diagnostic companies should look to recombinant replacementsDavid A. GeorgeDavid A. GeorgeDavid A. George is director of product research at Scripps Laboratories. Website: scrippslabs.com.Search for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.12AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:David A. George.Why Recombinants Are Essential for Assay Development and Production.Genetic Engineering & Biotechnology News.Oct 2023.28-31.http://doi.org/10.1089/gen.43.10.12Published in Volume: 43 Issue 10: October 13, 2023PDF download\",\"PeriodicalId\":50425,\"journal\":{\"name\":\"Genetic Engineering & Biotechnology News\",\"volume\":\"44 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genetic Engineering & Biotechnology News\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/gen.43.10.12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic Engineering & Biotechnology News","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/gen.43.10.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}

引用次数: 0

摘要

基因工程与生物技术新闻卷。翻译医学为什么重组对检测开发和生产至关重要斯克里普斯实验室说，如果无法获得天然蛋白，研究机构和诊断公司应该寻求重组蛋白的替代品。网站:scrippslabs.com.cn搜索本文作者的更多论文出版在线:2023年10月13日https://doi.org/10.1089/gen.43.10.12AboutSectionsView文章查看全文pdf /EPUB下载CitationsTrack CitationsAdd to favorites返回出版物ShareShare onFacebookTwitterLinked InRedditEmail查看文章figuresreferencesrelateddetails卷43发行10Oct 2023信息©2023 by GEN publishing引用本文:David A. George。为什么重组对检测开发和生产至关重要。基因工程与生物技术新闻。Oct 2023.28-31.http://doi.org/10.1089/gen.43.10.12Published in Volume: 43 Issue 10: October 13, 2023PDF下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Why Recombinants Are Essential for Assay Development and Production

Genetic Engineering & Biotechnology NewsVol. 43, No. 10 Translational MedicineWhy Recombinants Are Essential for Assay Development and ProductionScripps Laboratories says that if native proteins are unavailable, research organizations and diagnostic companies should look to recombinant replacementsDavid A. GeorgeDavid A. GeorgeDavid A. George is director of product research at Scripps Laboratories. Website: scrippslabs.com.Search for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.12AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:David A. George.Why Recombinants Are Essential for Assay Development and Production.Genetic Engineering & Biotechnology News.Oct 2023.28-31.http://doi.org/10.1089/gen.43.10.12Published in Volume: 43 Issue 10: October 13, 2023PDF download

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物

CiteScore

0.20

自引率

0.00%

发文量

210

审稿时长

3-6 weeks

期刊介绍： Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.